AI and the Future of BD and Investing: Smarter Diligence, Better Decisions

Session details:

• How AI is transforming BD and licensing from a slower, manual process into a more efficient and data-rich decision-making framework
• Tailoring AI to help teams evaluate molecules and programs in a more complete, 360-degree way
• How AI can surface risk, gaps, and liabilities earlier in diligence, supporting stronger partnership decisions
• How investors and strategics can use AI to reduce uncertainty and avoid costly mistakes
• How this shift could improve not just diligence, but the quality of innovation, commercialization, and value creation across the ecosystem at-scale